Short Report: Viking Therapeutics Short Interest At 5-Year High After VK273 Data
Short interest on Viking Therapeutics spikes to a five-year high above 30% while shares crater 36% as oral GLP-1 Phase 2 study fails to clear high expectations. Plus WULF, MLTX, SMR.
Why EVs Are Now Cheaper Than Gas Cars In China
Electric vehicles (EVs) have seen rapid adoption and price shifts globally, but affordability remains uneven across countries.